3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
24
Salivary Gland Neoplasms
2
Prostatic Neoplasms, Castration-Resistant
2
Prostatic Diseases
2
Non-metastatic Castration-resistant Prostate Cancer
2
Neoplasms
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Metastatic Castration-resistant Prostate Cancer
2
Male Urogenital Diseases
2
Bulbo-Spinal Atrophy, X-Linked
2
Adenocarcinoma
2
Urogenital Neoplasms
1
Urogenital Diseases
1
Sleep Initiation and Maintenance Disorders
1
Refractory or Relapsed Solid Tumors
1
Prostate Cancer Metastatic
1
Prostate Adenocarcinoma
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Metastatic Castration-resistant Prostate Neoplasms
1
High-Risk Localized Prostate Cancer
1
Granulosa cell tumor of the ovary
1
Genital Diseases, Male
1
Fatigue
1
Depression
1
Biochemically Recurrent Prostate Cancer
1
Advanced Solid Tumor
1
Interventions
ponatinib
4
Methotrexate
4
Cyclophosphamide
4
merphos
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Tacrolimus
2
Rituximab
2
Peripheral Blood Stem Cell Transplantation
2
Mycophenolic Acid
2
Melphalan
2
Cytarabine
2
CT-P10
2
Busulfan
2
venetoclax
1
prednylidene
1
pegylated granulocyte colony-stimulating factor
1
letermovir
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
deltacortene
1
blinatumomab
1
auricularum
1
Vincristine
1
Thiotepa
1
Stem Cell Transplantation
1
Specimen Handling
1
Sirolimus
1
Prednisone
1
N,N-dicyclohexyl-isoborneol-10-sulfonamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Accelerated Phase
×
darolutamide
×
90 days
×
Clear all
No trials found.